Vivos Therapeutics, Inc. (VVOS) stock
Close on Nov 12, 2026Market cap $1.93MP/E –Yield –
Vivos Therapeutics, Inc. grew revenue 45.2% to $20.90M over the twelve months to Jun 30, 2026. Free cash flow was -$19.01M. At the latest close the market valued the company at $1.93M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $1.93M
- P/E ratio
- –
- Price to sales
- 0.09
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- -987.54%
Fundamentals
- Revenue
- $20.90M
- Net income
- -$25.46M
- EPS, diluted
- -$1.88
- Free cash flow
- -$19.01M
- Book value per share
- -$0.22
- Diluted shares
- 18M
Trading
- Previous close
- $0.09
- Open
- $0.09
- Day's range
- $0.09 – $0.10
- Volume
- 508,554
- Average volume (20 days)
- 7,148,858
- Beta (5 years)
- 1.44
- 52-week range
- $0.09 – $2.72
- RSI (14 days)
- 31.0
- Volatility (1 year)
- 95.8%
- Relative volume
- 0.05×
- WACC
- 11.8%
Market cap history
Month-end market cap since 2020, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | VVOS | S&P 500 | Difference | VVOS per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -33.6% | -2.7% | −30.9 pts | ||
| 3 months | -66.5% | -1.7% | −64.8 pts | ||
| Year to date | -95.3% | +11.9% | −107.2 pts | ||
| 1 year | -96.2% | +12.0% | −108.2 pts | ||
| 3 years | -96.5% | +78.2% | −174.7 pts | -67.3% | +21.2% |
| 5 years | -99.9% | +73.2% | −173.1 pts | -75.0% | +11.6% |
Eight years at a glance
Fiscal years 2018 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Vivos Therapeutics filed with the SEC as exhibits to Form 8-K or 6-K
- News
- Update
- Update
- Update
- Update
- Update
About Vivos Therapeutics
Surgical & Medical Instruments & Apparatus
Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing non-surgical treatments for patients suffering from obstructive sleep apnea (OSA), snoring, and related dentofacial abnormalities. Its primary offering is The Vivos Method, a multi-disciplinary treatment protocol utilizing proprietary oral appliances alongside clinical guidance. The company also provides home sleep testing services—such as the SleepImage ring—myofunctional therapy, and medical billing intelligence services. Through its management organizations, the business supports affiliated sleep testing centers and treatment facilities. Vivos Therapeutics serves adult and pediatric patients diagnosed with sleep breathing disorders, offering its products and clinical support through dentists, medical sleep specialists, physicians, and affiliated clinical practices.
Company profile, executives and historyVivos Therapeutics stock: common questions
What is Vivos Therapeutics's stock price?
VVOS closed at $0.10 on Nov 12, 2026, up 5.75% on the day. Over the past 52 weeks it traded between $0.09 and $2.72.
What is Vivos Therapeutics's market cap?
Vivos Therapeutics was worth $1.93M at the close on Nov 12, 2026: the share price times the diluted shares outstanding.
What is VVOS's P/E ratio?
Vivos Therapeutics lost money over the twelve months to Jun 30, 2026 (diluted EPS -$1.88), so it has no meaningful P/E ratio.
How much revenue does Vivos Therapeutics make?
Vivos Therapeutics reported revenue of $20.90M for the twelve months to Jun 30, 2026, up 45.2% from a year earlier.
Does Vivos Therapeutics pay a dividend?
No. Vivos Therapeutics has not paid a cash dividend over the last twelve months.
How has VVOS stock performed over the past year?
Including dividends, VVOS returned -96.2% over the past year, against +12.0% for the S&P 500.
How many VVOS shares are sold short?
3M shares were sold short at the latest FINRA report, 21.90% of the float, or 1.0 days of average trading volume.
Who are Vivos Therapeutics's competitors?
Companies most similar to Vivos Therapeutics by business, industry and size include BTCY, SNOA, SRTS, BDMD, NMTC.
See a number that looks wrong?